SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E_K_S who wrote (69851)3/1/2022 10:39:49 PM
From: Spekulatius1 Recommendation

Recommended By
Lance Bredvold

  Read Replies (1) of 78802
 
Re VTRS - I sold at $11.2 for a more than 15% loss after reading the earnings release and reviewing the data, Forward guidance really is the problem, they guided down EBITDA by ~$500M for 2022.They also got much less for the biosimilar business than I thought.
The problem with VTRS that the equity is only a smallish part of the capital structure, at $10 equity is only roughly 1/3 of the capital structure. This means that in reality the stock is only ~3% cheaper on an EV basis when the equity is down 10%.

I just decided that I take my lumps and move on. I don’t need to make money with the same stock I lost it in.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News